Journey Medical Co. (NASDAQ:DERM) Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC boosted its position in Journey Medical Co. (NASDAQ:DERM) by 13.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 108,435 shares of the company’s stock after buying an additional 12,882 shares during the quarter. Geode Capital Management LLC owned 0.52% of Journey Medical worth $613,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Nwam LLC purchased a new stake in shares of Journey Medical during the third quarter worth about $59,000. Kovitz Investment Group Partners LLC purchased a new stake in Journey Medical during the 3rd quarter worth approximately $66,000. TMD Wealth Management LLC purchased a new stake in Journey Medical during the 2nd quarter worth approximately $65,000. ORG Wealth Partners LLC acquired a new position in shares of Journey Medical in the 3rd quarter valued at approximately $110,000. Finally, PVG Asset Management Corp purchased a new position in shares of Journey Medical during the 2nd quarter valued at approximately $894,000. Institutional investors and hedge funds own 7.25% of the company’s stock.

Journey Medical Stock Down 4.3 %

DERM stock opened at $3.83 on Friday. The company has a market capitalization of $80.01 million, a P/E ratio of -4.07 and a beta of 1.00. The firm has a 50 day simple moving average of $4.96 and a 200-day simple moving average of $5.23. The company has a current ratio of 1.38, a quick ratio of 1.03 and a debt-to-equity ratio of 1.81. Journey Medical Co. has a twelve month low of $2.85 and a twelve month high of $6.89.

Journey Medical Company Profile

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.